The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Jorden David Emerson since 2016.
This trader's CIK number is 1313516.
At the time of last reporting, Jorden David Emerson was the CEO/CFO of Nuo Therapeutics, Inc.. (stock ticker symbol AURX).
Also see all insider trading activities at Nuo Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | PLXP | 32,727 | $224,998 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | AURX | 0 | $0 | 0 | $0 | 192,710 | $77,084 |
2022 | AURX | 0 | $0 | 325,000 | $487,500 | 0 | $0 |
2017 | AURX | 247,500 | $54,945 | 0 | $0 | 0 | $0 |
2016 | AURX | 137,500 | $137,500 | 0 | $0 | 0 | $0 |
2. Nuo Therapeutics, Inc. (AURX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-06-14 | PLXP | Buy | 32,727 | 6.88 | 224,998 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-01 | AURX | Option Ex | 192,710 | .40 | 77,084 |
2022-11-09 | AURX | Sale | 162,500 | 1.50 | 243,750 |
2022-11-09 | AURX | Sale | 162,500 | 1.50 | 243,750 |
2017-08-10 | AURX | Buy | 247,500 | .22 | 54,945 |
2016-05-05 | NONE | Buy | 137,500 | 1.00 | 137,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jorden David Emerson (CEO/CFO of Nuo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.